My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2015
TOP STORIES
Bipartisan Antibiotic and Diagnostic Tax Credit Bill Introduced in Congress
Reps. Charles Boustany (R-LA), Mike Thompson (D-CA), Erik Paulsen (R-MN), John Shimkus (R-IL) and Gene Green (D-CA) introduced the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539, on Sept. 17.  Championed by IDSA, the READI Act would provide a new 50% tax credit for phase two and three clinical trials (similar to the successful Orphan Drug tax credit) to support the research and development of new antibiotics and antifungal drugs that treat serious or life-threatening infections and address an unmet medical need. The bill also supports R&D of new rapid ID diagnostic tests that provide results in under four hours.  IDSA secured broad stakeholder support for the READI Act, including from other medical, scientific, and healthcare provider societies; patient groups; industry; and public health.  

To help READI advance in Congress, we need more representatives to cosponsor this bill.  You can help by taking three minutes to email your representative with a request prepared by IDSA through this link.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
CDC Investigates Multistate Outbreak of Listeriosis Linked to Soft Cheeses
POLICY AND ADVOCACY
IDSA Leaders Appointed to New Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
IDSA and HIVMA “Rally for Medical Research”
S-FAR Holds Strategy Meeting with over 50 Partner Organizations
GLOBAL ID
Science Speaks Reports on New HIV and TB Resources
EDUCATION AND RESOURCES
IDSA Education and Research Foundation to Host Donors’ Lounge at IDWeek 2015
Thank You—We Couldn't Have Done it Without You
IDSA Education and Research Foundation Announces New Award in Memory of Robert C. Moellering, MD, FIDSA
ASP Announces Accreditation Seminar
YOU AND YOUR COLLEAGUES
Member Report
FROM THE PRESIDENT
From Ebola, Antibiotic Resistance and ABIM to Strategic Planning…A Year in Review
TOP STORIES
Bipartisan Antibiotic and Diagnostic Tax Credit Bill Introduced in Congress
Drug Company Reverses 5,000% Increase in Drug Price
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.